Should human milk-based nutritional products for premature infants be homogenized? More research is needed, new journal article says
Type: Press Releases
Topic(s): Clinical Studies on Prolact/Humavant CR Company Pasteurization Product
Prolacta Bioscience enrolls first infant in Japan-based clinical trial to evaluate the effect of an Exclusive Human Milk Diet on growth and safety in premature infants
Type: Press Releases
Topic(s): Clinical Studies
Prolacta Bioscience Appoints Dr. Anne Beal to Board of Directors
Type: Press Releases
Topic(s): Company
Prolacta Bioscience Celebrates Prematurity Awareness Month by Recognizing Breast Milk Donors for Their Contributions to Premature Infants in the NICU
Type: Press Releases
Topic(s): Donors Helping Hands Tiny Treasures
Prolacta Bioscience Develops World’s First Test to Directly Detect Bacteria and Viruses, Including SARS-CoV-2, in Donor Breast Milk
Type: Press Releases
Topic(s): Company
Mindy Fuzesy presents at Association of Women's Health, Obstetric and Neonatal Nurses 2021 virtual convention
Type: Press Releases
Topic(s): Conferences and Events Pasteurization
Prolacta Bioscience continues Advancing the Science of Human Milk, proud to partner with NICU teams in saving lives of premature infants
Type: Press Releases
Topic(s): Company Healthcare Professionals
Association of Women’s Health, Obstetric, & Neonatal Nurses (AWHONN) encourages an exclusive human milk diet (EHMD) for vulnerable preterm infants in the neonatal intensive care unit (NICU)
Type: Press Releases
Topic(s): Advocacy Bronchopulmonary Dysplasia (BPD) Feeding Intolerance Late-Onset Sepsis Mortality Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)
Prolacta Bioscience hosts panel session on the need for uniform human milk safety standards at 2021 National Coalition for Infant Health Summit
Type: Press Releases
Topic(s): Advocacy Company Quality & Safety